Effectiveness of BNT162b2 Vaccine Against Symptomatic SARS-CoV-2 Infection in Children Aged 5–11 Years in Japan During Omicron Variant Predominate Periods

Effectiveness of BNT162b2 Vaccine Against Symptomatic SARS-CoV-2 Infection in Children Aged 5–11 Years in Japan During Omicron Variant Predominate Periods

Background: Although the effectiveness of BNT162b2 messenger RNA vaccines against the Omicron variant has been reported in several countries, data are limited in children living in Asian countries. Therefore, this study aimed to estimate the effectiveness of the pediatric primary two-dose monovalent...

Full description

Bibliographic Details
Main Authors: Megumi Hara, Yuko Ohta, Naoki Fusazaki, Yoshio Hirota
Format: Article
Language:English
Published: Japan Epidemiological Association 2024-05-01
Series:Journal of Epidemiology
Subjects:
coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
omicron
vaccine
child
Online Access:https://www.jstage.jst.go.jp/article/jea/34/5/34_JE20230093/_pdf

Internet

https://www.jstage.jst.go.jp/article/jea/34/5/34_JE20230093/_pdf

Similar Items